Drug Profile
NPP5
Latest Information Update: 22 Aug 2002
Price :
$50
*
At a glance
- Originator Crystal Recovery Systems
- Developer Crystal Recovery Systems; MDM Group
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 30 Dec 1998 New profile
- 30 Dec 1998 Phase-I clinical trials for Cancer in USA (SC)